World Library  
Flag as Inappropriate
Email this Article


Article Id: WHEBN0000376664
Reproduction Date:

Title: Dexbrompheniramine/pseudoephedrine  
Author: World Heritage Encyclopedia
Language: English
Subject: Decongestants, H1 receptor antagonists, Triprolidine, Desloratadine, Mepyramine
Publisher: World Heritage Encyclopedia


Combination of
Dexbrompheniramine Antihistamine
Pseudoephedrine Decongestant
Clinical data
Trade names Drixoral
  • US: C (Risk not ruled out)
Legal status
ATC code R06

Dexbrompheniramine/pseudoephedrine (trade name Drixoral) is a combination medication that contains the antihistamine dexbrompheniramine maleate and the decongestant pseudoephedrine sulfate. It is manufactured by Schering-Plough and is used to treat symptoms associated with allergies and colds such as itchy and watery eyes, runny nose, nasal and sinus congestion, and sneezing. Because it contains pseudoephedrine, its purchase in the United States has been severely restricted by the Combat Methamphetamine Epidemic Act of 2005 over fears that any product containing pseudoephedrine can be used to make methamphetamine.[1]

As of 2008, Drixoral has been removed from the US market by manufacturer Merck (formerly Schering-Plough). The company's updated website attributes "changing [their] manufacturing location" for the supply disruption and currently states "it is unlikely product will be available in 2010".[2] However, the drug still appears to be available in Canada and overseas,[3][4] and other drugs manufactured at the same location have not become unavailable. This has led some Drixoral users to speculate that there may be other explanations for why Drixoral is no longer available in the US market. One possible reason is that the company is reformulating the product to no longer contain pseudoephedrine. Another possibility is that the 35-year-old drug is being removed in favor of newer, more profitable antihistamines such as Claritin (also manufactured by Schering-Plough). Some Drixoral users have resorted to ordering the drug from Canadian online pharmacies. The drug was removed from the Turkish market in 2012.


  1. ^ Payne, January W. (March 9, 2009). "Drixoral: Why the Allergy Medicine Isn't Available, and What to Use Instead" (html).  
  2. ^ "Products Currently Unavailable" (html). Merck. 2010. Retrieved 2010-05-18. 
  3. ^ "Drixoral Canada" (html). Schering Plough. 2010. Retrieved 2010-02-22. 
  4. ^ "Buy Drixoral" (html). Canada Medicine Shop. 2010. Retrieved 2010-02-22. 

This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from World eBook Library are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.